237 related articles for article (PubMed ID: 12954186)
1. Caco-2 permeability, P-glycoprotein transport ratios and brain penetration of heterocyclic drugs.
Faassen F; Vogel G; Spanings H; Vromans H
Int J Pharm; 2003 Sep; 263(1-2):113-22. PubMed ID: 12954186
[TBL] [Abstract][Full Text] [Related]
2. Predicting P-glycoprotein effects on oral absorption: correlation of transport in Caco-2 with drug pharmacokinetics in wild-type and mdr1a(-/-) mice in vivo.
Collett A; Tanianis-Hughes J; Hallifax D; Warhurst G
Pharm Res; 2004 May; 21(5):819-26. PubMed ID: 15180340
[TBL] [Abstract][Full Text] [Related]
3. Carbamazepine is not a substrate for P-glycoprotein.
Owen A; Pirmohamed M; Tettey JN; Morgan P; Chadwick D; Park BK
Br J Clin Pharmacol; 2001 Apr; 51(4):345-9. PubMed ID: 11318771
[TBL] [Abstract][Full Text] [Related]
4. Role of P-glycoprotein-mediated secretion in absorptive drug permeability: An approach using passive membrane permeability and affinity to P-glycoprotein.
Döppenschmitt S; Spahn-Langguth H; Regårdh CG; Langguth P
J Pharm Sci; 1999 Oct; 88(10):1067-72. PubMed ID: 10514357
[TBL] [Abstract][Full Text] [Related]
5. Dose-dependent targeted suppression of P-glycoprotein expression and function in Caco-2 cells.
Lee SD; Osei-Twum JA; Wasan KM
Mol Pharm; 2013 Jun; 10(6):2323-30. PubMed ID: 23611024
[TBL] [Abstract][Full Text] [Related]
6. Intestinal transport of irinotecan in Caco-2 cells and MDCK II cells overexpressing efflux transporters Pgp, cMOAT, and MRP1.
Luo FR; Paranjpe PV; Guo A; Rubin E; Sinko P
Drug Metab Dispos; 2002 Jul; 30(7):763-70. PubMed ID: 12065434
[TBL] [Abstract][Full Text] [Related]
7. Differences in P-glycoprotein activity in human and rodent blood-brain barrier assessed by mechanistic modelling.
Verscheijden LFM; Koenderink JB; de Wildt SN; Russel FGM
Arch Toxicol; 2021 Sep; 95(9):3015-3029. PubMed ID: 34268580
[TBL] [Abstract][Full Text] [Related]
8. A Practical Perspective on the Evaluation of Small Molecule CNS Penetration in Drug Discovery.
Huang L; Wells MC; Zhao Z
Drug Metab Lett; 2019; 13(2):78-94. PubMed ID: 30854983
[TBL] [Abstract][Full Text] [Related]
9. Drug-induced trafficking of p-glycoprotein in human brain capillary endothelial cells as demonstrated by exposure to mitomycin C.
Noack A; Noack S; Hoffmann A; Maalouf K; Buettner M; Couraud PO; Romero IA; Weksler B; Alms D; Römermann K; Naim HY; Löscher W
PLoS One; 2014; 9(2):e88154. PubMed ID: 24505408
[TBL] [Abstract][Full Text] [Related]
10. Interplay between CYP3A-mediated metabolism and polarized efflux of terfenadine and its metabolites in intestinal epithelial Caco-2 (TC7) cell monolayers.
Raeissi SD; Hidalgo IJ; Segura-Aguilar J; Artursson P
Pharm Res; 1999 May; 16(5):625-32. PubMed ID: 10350002
[TBL] [Abstract][Full Text] [Related]
11. Delineating the contribution of secretory transporters in the efflux of etoposide using Madin-Darby canine kidney (MDCK) cells overexpressing P-glycoprotein (Pgp), multidrug resistance-associated protein (MRP1), and canalicular multispecific organic anion transporter (cMOAT).
Guo A; Marinaro W; Hu P; Sinko PJ
Drug Metab Dispos; 2002 Apr; 30(4):457-63. PubMed ID: 11901101
[TBL] [Abstract][Full Text] [Related]
12. In vitro interactions between aged garlic extract and drugs used for the treatment of cardiovascular and diabetic patients.
Berginc K; Žakelj S; Kristl A
Eur J Nutr; 2010 Sep; 49(6):373-84. PubMed ID: 20140680
[TBL] [Abstract][Full Text] [Related]
13. Assessment of active transport of HIV protease inhibitors in various cell lines and the in vitro blood--brain barrier.
van der Sandt IC; Vos CM; Nabulsi L; Blom-Roosemalen MC; Voorwinden HH; de Boer AG; Breimer DD
AIDS; 2001 Mar; 15(4):483-91. PubMed ID: 11242145
[TBL] [Abstract][Full Text] [Related]
14. Efflux ratio cannot assess P-glycoprotein-mediated attenuation of absorptive transport: asymmetric effect of P-glycoprotein on absorptive and secretory transport across Caco-2 cell monolayers.
Troutman MD; Thakker DR
Pharm Res; 2003 Aug; 20(8):1200-9. PubMed ID: 12948018
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of a vincristine resistant Caco-2 cell line for use in a calcein AM extrusion screening assay for P-glycoprotein interaction.
Eneroth A; Aström E; Hoogstraate J; Schrenk D; Conrad S; Kauffmann HM; Gjellan K
Eur J Pharm Sci; 2001 Jan; 12(3):205-14. PubMed ID: 11113639
[TBL] [Abstract][Full Text] [Related]
16. Role of P-glycoprotein in the intestinal absorption of glabridin, an active flavonoid from the root of Glycyrrhiza glabra.
Cao J; Chen X; Liang J; Yu XQ; Xu AL; Chan E; Wei D; Huang M; Wen JY; Yu XY; Li XT; Sheu FS; Zhou SF
Drug Metab Dispos; 2007 Apr; 35(4):539-53. PubMed ID: 17220245
[TBL] [Abstract][Full Text] [Related]
17. Affinity for the P-glycoprotein efflux pump at the blood-brain barrier may explain the lack of CNS side-effects of modern antihistamines.
Chishty M; Reichel A; Siva J; Abbott NJ; Begley DJ
J Drug Target; 2001 Jun; 9(3):223-8. PubMed ID: 11697207
[TBL] [Abstract][Full Text] [Related]
18. Impact of P-glycoprotein-mediated intestinal efflux kinetics on oral bioavailability of P-glycoprotein substrates.
Kwon H; Lionberger RA; Yu LX
Mol Pharm; 2004; 1(6):455-65. PubMed ID: 16028357
[TBL] [Abstract][Full Text] [Related]
19. Steady-state brain concentrations of antihistamines in rats: interplay of membrane permeability, P-glycoprotein efflux and plasma protein binding.
Mahar Doan KM; Wring SA; Shampine LJ; Jordan KH; Bishop JP; Kratz J; Yang E; Serabjit-Singh CJ; Adkison KK; Polli JW
Pharmacology; 2004 Oct; 72(2):92-8. PubMed ID: 15331914
[TBL] [Abstract][Full Text] [Related]
20. Role of P-glycoprotein on the CNS disposition of amprenavir (141W94), an HIV protease inhibitor.
Polli JW; Jarrett JL; Studenberg SD; Humphreys JE; Dennis SW; Brouwer KR; Woolley JL
Pharm Res; 1999 Aug; 16(8):1206-12. PubMed ID: 10468021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
